Viatris Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $4.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $12.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-07-01 to 2022-09-30 | $2.33bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-01-01 to 2022-09-30 | $7.16bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-07-01 to 2022-09-30 | $1.75bn | us-gaap:GrossProfit |
| Gross profit | 9 months2022-01-01 to 2022-09-30 | $5.22bn | us-gaap:GrossProfit |
| Research and development | 3 months2022-07-01 to 2022-09-30 | $174.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-01-01 to 2022-09-30 | $479.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-07-01 to 2022-09-30 | $1.02bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-01 to 2022-09-30 | $2.91bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | $560.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | $1.82bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-07-01 to 2022-09-30 | $153.2m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-01-01 to 2022-09-30 | $445.3m | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $73.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $276.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $354.3m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months2022-01-01 to 2022-09-30 | $1.07bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | $0.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | $0.88 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $0.88 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 1,218,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 1,216,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $2.81bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $252.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-09-30 | $646.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $10.49bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $48.66bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $6.52bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $29.48bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-09-30 | $18.72bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-09-30 | $763.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2022-09-30 | $500.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-09-30 | $19.18bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001792044-22-000036. Last ingested by Listed: Nov 6, 2026, 12:37 ET. Listed shows no prices and gives no investment advice.